FUNCTIONAL FOODS. separating fact from fiction Lt.cdr Rabia Anwer - - PowerPoint PPT Presentation

functional foods
SMART_READER_LITE
LIVE PREVIEW

FUNCTIONAL FOODS. separating fact from fiction Lt.cdr Rabia Anwer - - PowerPoint PPT Presentation

FUNCTIONAL FOODS. separating fact from fiction Lt.cdr Rabia Anwer (PN) DIETITIAN PNS SHIFA 1. To understand functional foods & their categories. 2. Regulation of functional foods 3. Examples of functional foods available in Pakistan and


slide-1
SLIDE 1

FUNCTIONAL FOODS. separating fact from fiction

Lt.cdr Rabia Anwer (PN) DIETITIAN PNS SHIFA

slide-2
SLIDE 2
  • 1. To understand functional foods & their

categories.

  • 2. Regulation of functional foods
  • 3. Examples of functional foods available

in Pakistan and their mode of action.

  • 4. Functional food health claims and

review of research.

  • 5. Take home message for dietetic

professionals.

slide-3
SLIDE 3

 The Academy of Nutrition and Dietetics

defines FUNCTIONAL FOOD as: A food that provides additional health benefits that may reduce disease risk and/or promote good health.

Position of The American Dietetic Association: Functional foods. J Am Diet Assoc. 2009;104:736

slide-4
SLIDE 4

 The functional food term was introduced in

Japan in the 1980’s- foods fortified with specific ingredients imparting certain health benefits.

Japanese people have the longest life expectancy in the world---Increase the cost of health care

Japanese society, being aware of the aging process, has become more concerned with the prevention of the lifestyle related diseases through daily diet.

 Decrease the cost of health care.

(Recent trends in functional food science and the industry in Japan. Biosci Biotechnol Biochem.

2002;66:2017-2029.)

slide-5
SLIDE 5

Unmodified whole foods such as fruits and vegetables represent the simplest form of a functional food.

 Tomatoes ,raspberries

broccoli are rich in bioactive components as

 Lycopene  Ellagic acid  Lutein  Sulforaphane

slide-6
SLIDE 6

Include foods that have been modified through fortification, enrichment, or enhancement

 Iodized salt  Milk fortified with vitamin D  Foods enhanced with bioactive components,

such as margarines containing plant sterol esters

 Beverages enhanced with energy-promoting

ingredients such as ginseng, guarana, or taurine.

slide-7
SLIDE 7

 Formulated for specific dietary management

  • f disease .

 To be administered under the supervision of

health care professional

 Include Phenylketonuria formulas,

diabetic, renal, and liver formulations

slide-8
SLIDE 8

 Include foods that fill special dietary needs

that are due to specific health conditions, such as celiac disease, lactose intolerance,

  • r obesity.

Examples : Infant foods, hypoallergenic foods

such as gluten-free and lactose-free foods, and foods for weight reduction.

Position of The American Dietetic Association: Functional foods. J Am Diet Assoc.2009;104:736

slide-9
SLIDE 9

 Isolated or purified from foods  Generally sold in medicinal forms  Not usually associated with food  Demonstrated to have a physiological

benefit or provide protection against chronic disease

Policy paper—Nutraceuticals/functional foods and health claims on foods. Health Canada Web site.http://www.hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/nutra- funct_foods-nutra-fonct_aliment-eng.php.

slide-10
SLIDE 10

Japan FOSHU

1991 Food for specified health use Approved by Ministry of Health and Welfare

Europe

FUFOSE Concerted action PASSCLAIM Functional food science in Europe . Process for the Assessment of Scientific Support for Claims on foods.

United states

FDA 1993

  • 1. Nutrient content claims.

2. Structure and function claims. 3. Health claims IFIC-2011

slide-11
SLIDE 11

FUNCTIONAL FOOD ACTIVE FOOD COMPONENT TARGET FUNCTION TOMATOES WATERMELON LYCOPENE Antioxidant ,may reduce risk of some cancers GREEN TEA CATECHINS FLAVONOLS Antioxidants ,may reduce risk of some cancers YOGURT Probiotics: Lactobacillus sp. Bifidobacteria sp Prebiotics: inulin and oligofructose. Optimal intestinal function and intestinal microbial balance FISH/FISH OIL OMEGA 3 ENRICHED EGGS Omega 3 fatty acids Control of hypertension, lipids metabolism

slide-12
SLIDE 12
slide-13
SLIDE 13

“ Live microorganisms, which, when administered in adequate amounts, confer a health benefit on the host.“

(FAO/WHO, 2001).

slide-14
SLIDE 14

 Probiotic microorganisms

can be found in both supplement form and as components of foods and beverages.

 Certain yogurts and

  • ther cultured dairy

products contain such helpful bacteria, particularly specific strains of Bifidobacteria and Lactobacilli.

slide-15
SLIDE 15

HEALTHY GUT FLORA

HELPS IN THE ABSORPTION OF NUTRIENTS FROM FOOD AND WATER

FILTERS/ ELIMINATE HARMFUL BACTERIA TOXINS CHEMICALS

slide-16
SLIDE 16

 Balance the flora, increasing the number of helpful, and

reducing (inhibiting the growth of) harmful bacteria, in the intestine.

 Modify the gut immune response and improve its barrier

  • function. For example, specific probiotic species can

shorten or reduce the risk of certain infections , and autoimmune disorders (ulcerative colits ,Crohn’s disease and rheumotoid), and infections ( infectious diarrhea, Helicobacter pylori).

 Modulate/adjust the activity of the immune system,

helping to control or reduce the development of certain allergies.

Ashwell M. Concepts of Functional Foods(ILSI Europe Concise Monograph Series Ed Walker, R) 2002.

slide-17
SLIDE 17

 No proven role in inducing or maintaining

remission in Crohn disease.

 Studies report amelioration of symptoms such

as bloating, abdominal pain or colonic transit.

 Many of the studies were fairly short and do not

reflect improvement in the quality of life.

Journal of Pediatric Gastroenterology and Nutrition 43:550Y557 October 2006 Lippincott Williams & Wilkins, Philadelphia

slide-18
SLIDE 18

 Meta-analyses suggest a reduction in AAD

by approximately 60%.

 Not all strains are effective.  S. boulardii and Lactobacillus GG

Journal of Pediatric Gastroenterology and Nutrition 43:550Y557 October 2006 Lippincott Williams & Wilkins, Philadelphia

Efficacy suggested with E. coli to be equivalent to mesalamine in some studies.

slide-19
SLIDE 19

 Beneficial effects in mild to moderate

infectious diarrhea.

 Overall reduction in the duration of diarrhea

by about 1 day .

 Lactobacillus GG showed consistent benefit  No demonstrable benefit reported in children

with more severe diarrhea

Journal of Pediatric Gastroenterology and Nutrition 43:550Y557October 2006 Lippincott Williams & Wilkins, Philadelphia

slide-20
SLIDE 20

 Modestly beneficial  When prescribing probiotics, the probiotic

formulation, including live, dead, compounded preparations, the effective dose to use and the type of disease targeted must be considered.

 FDA does not currently regulate probiotic

products.

 No quality control governing agency - actual

number of viable organisms may be different from what is being advertised

Clinical Practice Guideline- Pediatr Gastroenterol Nutr, Vol. 43, No. 4, October 2006).

slide-21
SLIDE 21

Prebiotics are defined as “nondigestible food

ingredients that beneficially affect the host by selectively stimulating the growth of one or a limited number of bacterial species in the colon, such as Bifidobacteria and Lactobacilli, which have the potential to improve host health.”

Ashwell M. Concepts of Functional Foods (ILSI Europe Concise Monograph Series Ed Walker, R) 2002.

slide-22
SLIDE 22

 Fructo -oligosaccharide

(FOS)

 Inulin  Poly dextrose  Lactulose  Resistant starch

 Inulin and oligofructose are

amongst the most studied and well established

SOURCES

 Whole grains – oat

meal, flax barley

 Garlic  onion  Honey  Legumes  Green leafy vegetables  Berries  Bananas

slide-23
SLIDE 23

 Promote the growth and proliferation of

beneficial bacteria in the intestinal tract, and thus enhance the effect of probiotic bacteria .

 Increase calcium absorption, thus improve both

bone mineral content and bone mineral density (BMD)

(Bosscher et al., Journal of Nutrition 2006).

 They influence the regulation of blood glucose,

and reduce the levels of cholesterol and serum lipids

(Lo´pez-Molina et al Journal of Nutrition., 2005).

slide-24
SLIDE 24

Dietar etary synbio biotics tics red educe ce ca cancer cer risk fac actors s in polyp lypect ctom

  • mized

ized an and co colon lon ca cancer cer pat atients ents

A large study sponsored by the EU found that a mix

  • f both probiotics and prebiotics largely modified the

composition of the colonic bacterial ecosystem, and could in this way diminish the amount of cancer- promoting bacteria. The number of Clostridium perfringens, a bacterial strain thought to convert dietary substances to carcinogenic compounds, decreased notably in participants given the synbiotic product. Use of synbiotics may be chemoprevention of colon cancer in humans.

American Journal of Clinical Nutrition Volume 85, Pages 488-496 Feb.2007

slide-25
SLIDE 25

Cli linical nical eval aluation ation of a n a new w sta tarter er formu mula la for infan ants ts co conta taining ining li live Bi Bifidobact

  • bacteriu

erium m lo longum um BL BL99 999 9 an and prebio biotics tics:

 A study by Nestle found that formula with

Bifidobacterium longum and the prebiotics GOS and FOS was beneficial to the general health of infants.

 study covered 138 infants, each of them given

either a synbiotic mix (with both prebiotics and probiotics) in their formula, or a placebo control.

 The conclusion was that children with the

synbiotic mix had less incidences of constipation, as well as less infections of the respiratory tract

Nutrition January 2007, Volume 23, Issue 1, Pages 1-8

slide-26
SLIDE 26

 are long-chain, polyunsaturated fatty acids

POLYUNSATURATED FATTY ACIDS (PUFAs)

OMEGA-3 fatty acids OMEGA-6 fatty acids ALA-alpha-linolenic acid LA- linoleic acid

slide-27
SLIDE 27

 Help lower elevated triglycerides levels.  Reduce the blood tendency to clot which

may reduce atherosclerosis

 Reduce the inflammation involved in

Rheumatoid arthritis.

 Improved symptoms and mental health

disorders.

slide-28
SLIDE 28

ALA-0mega 3 fatty acid LA-0mega 6 fatty acid DHA EPA

AA

Brain development &

EICOSANOIDS

Function

includes (prostaglandins,thromboxanes,leukotrines)

cell division , growth, blood clotting, muscle activity, secretion of digestive juices and hormones, and movement of substances like calcium into and out of cells

slide-29
SLIDE 29

 Eicosanoids formed from AA ( series-2 prostaglandins

& series-4 leukotrienes) are released in the body in response to injury, infection, stress, or certain diseases. They increase platelet aggregation and enhance vasoconstriction and the synthesis of substances involved with the inflammatory process.

 Eicosanoids derived from EPA (series-3 prostaglandins),

in contrast, decrease excessive series-2 prostaglandin

  • production. As a result, adequate production of EPA-

derived series-3 prostaglandins may help protect individuals against heart attacks and strokes as well as certain inflammatory diseases such as arthritis, and asthma.

Dietary Supplement Fact Sheet :NIH

  • ds.od.nih.gov/factsheets/Omega3FattyAcidsandHealth-HealthProfessional/
slide-30
SLIDE 30

 ALA: flax seeds, flaxseed oil, linseed

  • il, rapeseed oil, canola oil, soybean
  • il, pumpkin seeds, and walnuts

 EPA and DHA: fish oils , and fish

particularly from cold-water such as salmon,rohu, trout, gulfam, and mahaseer.

slide-31
SLIDE 31

Effects ects of Ecosap sapen enta taen enoic

  • ic acid

id on Cardi diovascula scular r even ents in in Ja Japa panes ese pat e patie ients wit ith cholest ester erolemi

  • lemia

(JELIS-2005) 2005)

rr

50% EPA Group 50% Control group

15000 subjects No prior history

  • f coronary

artery disease Highly purified fish oil capsules (1800mg) + Statins ( 5 mg) Statins ( 5mg) 3600 subjects History of coronary artery disease Highly purified fish oil capsules(1800mg) + Statins (5 mg) Statins (5 mg) PRIMARY ENDPOINT of major coronary events( sudden cardiac death, fatal

  • r nonfatal myocardial infarction (MI), unstable angina pectoris, and coronary

artery bypass graft/ percutaneous coronary intervention (CABG/PCI)

slide-32
SLIDE 32

 Mean total and (LDL)-cholesterol levels in the

JELIS participants at baseline were 275 mg/dl and 180 mg/dl .

 At the end of the study, total cholesterol and

LDL-cholesterol levels were reduced equivalently in both treatment groups, by 19% and 26%, respectively.

 Triglycerides were reduced by 10% in the EPA

group vs 5% in the control group.

 High-density lipoprotein (HDL)-cholesterol

remained stable throughout the study.

slide-33
SLIDE 33

 In the 3664 subjects with a history of CAD, EPA was

associated with a significant 19% reduction in major coronary events compared with the control group . Unstable angina was also significantly reduced in the EPA group by 28%.

 In the 14,981 subjects with no history of coronary

artery disease (CAD), major coronary events were reduced by 18% in the EPA group compared to the controls .

 There was no significant difference in all-cause

mortality between the 2 treatment groups

American Heart Journal. 2003 Oct;146(4):613-20

slide-34
SLIDE 34

 The American Heart Association

recommends 500 milligrams of DHA and EPA per day, the equivalent of two servings of fish per week.

 For those with allergies or a distaste for

fish, an omega-3 supplement could help maintain and improve heart health

slide-35
SLIDE 35

 Belongs to legume

family

 Isoflavones  phytoestrogens  Highest protein content

among legumes

 Contains all 8 essential

amino acids

 Low in saturated fat  omega 3 & 6 fatty

acids

slide-36
SLIDE 36

 Reduce risk of heart disease  Reduce risk of certain types of cancer  Reduce vasomotor symptoms (hot

flashes) in menopausal women.

slide-37
SLIDE 37

In 2006 the AHA Nutrition committee

released results of 22 randomized trials .

 Soya proteins & isoflavones have not been

shown to lesson vasomotor symptoms of menopause.

 Show no significant effects on HDL

cholesterol or triglycerides. Journal of Nutrition,2006

slide-38
SLIDE 38

 Moderate intake do not cause

hypothyroidism.

 Soy isoflavones may take up some of the

iodine that the body would normally use to make thyroid hormone.

 Increase iodine in diets.  Reduce the absorption of medicines used

to treat hypothyroidism.

THYROID 2006 Mar;16(3):249-58.

slide-39
SLIDE 39

 Subjects: 5,042 women previously diagnosed with breast cancer  Duration :4 yrs  Information on cancer diagnosis/ treatment/ lifestyle exposures after

cancer diagnosis and disease progression was collected at 6 months after cancer diagnosis and was reassessed at 3 follow-up interviews conducted at 18, 36, and 60 months after diagnosis.

 Medical charts were reviewed to verify disease and treatment

information.

 Main Outcome Measures: Total mortality and breast cancer recurrence

  • r breast cancer–related deaths.

 Soy food intake was measured by food frequency questionnaire.

XO, Zheng Y, Cai H, et al. Soy food intake and breast cancer survival. JAMA. 2009;302:2437-2443.)

slide-40
SLIDE 40

 444 deaths & 534 recurrence deaths were

documented in 5033 surgically treated breast cancer patients.

 Soy food consumption was significantly

associated with decreased risk of death and recurrence .

 32 % lower risk of recurrence  29 % decreased risk of death

slide-41
SLIDE 41

 Stay informed  Consumer Education  Research

slide-42
SLIDE 42

 Functional foods may enhance health

but they are not a magic bullet

 There are no "good" or "bad" foods, but

there are good or bad diets. Emphasis must be placed on over-all dietary pattern

 Field of functional foods, however, is in

its infancy

slide-43
SLIDE 43